Adalvo's rare disease portfolio encompasses a diverse array of treatments designed to target several rare diseases. Each dossier within our portfolio is developed to improve the quality of life and prognosis for patients facing these often-overlooked conditions.
At Adalvo, we understand the complexities associated with rare diseases and the profound impact they have on patients and their families.
Explore our rare disease portfolio below.
At Adalvo, there are no half-measures – we are always on target. When your mission is to be faster and stronger than your competitors, you need a winning team driving your vision forward.
Partner up now!
paulo.rodriguez@adalvo.com – Europe
marta.puig@adalvo.com - South Europe
marc.nolasco@adalvo.com - West Europe
jose.rendueles@adalvo.com- North Europe, CEE & APAC
supreet.sharma@adalvo.com – North America & Canada
camila.reinoso@adalvo.com - LATAM (exc. Brazil)
bruno.alves@adalvo.com - Brazil & MENA
ajish.rajan@adalvo.com – Brands & Specialty Products
arni.baldursson@adalvo.com - Head of Global BD&L
Click on your preferred Business Partner and get in touch today!